Xiogenix

Our team isn’t the only one making the trip to AATB 2026. 👀 Todd Farley, Jacqueline Behring, Thor Holmgren, Rachel Bahr, Griffen Kaiser, and Parker Glissendorf, CTBS will be in San Francisco, along with a lineup of Xiogenix tissue processing equipment. 👉 Swipe to see what we’re bringing and be sure to visit Booth #215 to talk about improving your tissue banking workflow. October 4–7 | Booth #215 #AATB2026 #TissueBanking #TissueProcessing #Xiogenix

Xiogenix is heading to Meeting on the Mesa, October 5–7, to talk automation, innovation, and downstream formulation & fill-finish solutions. 🌵 Meet with us about: - Scaling downstream workflows from development toward larger-scale manufacturing - Maintaining closed processing as workflows evolve - Reducing manual processing and operator time through automation - Building flexibility across bag, vial, or combined workflows - Support on fill accuracy, cell suspension, viability, and product quality - Configurable single-use solutions built around process requirements We’re focused on helping advance downstream cell and gene therapy manufacturing with practical automation and flexible process solutions. Rachel Bahr, Allie Schroeder, Joshua Jendusa, MBA, and Kate Pavletich are looking forward to connecting with the leaders and innovators moving the field forward. Contact our team to set up time at Meeting on the Mesa.

The best products solve a problem someone is already facing. And the best solutions come from teams that listen closely, learn quickly and keep asking what could work better. Our customers are at the center of how we innovate. We dig into their processes, understand the real pain points and bring our team together to build solutions that make a difference. That is how we grow: staying curious, solving what matters and moving forward alongside our customers. What process challenge is your team working to solve? Let’s talk. 👉 https://lnkd.in/gJE9JrhU #Xiogenix #ProcessInnovation #EngineeringSolutions

We are #Hiring! We're looking for a Cleanroom Assembler to join our Operations team in Muskego, WI. If you're detail-oriented, enjoy working in a hands-on manufacturing environment, and are passionate about quality, this could be the perfect opportunity for you! 🩵

The therapy should define the workflow, not the other way around. That’s where the ARES™ X20+ Fill-Finish System comes in. It supports bag workflows, vial workflows, or a combination of both, while bringing formulation, cooling, filling, and product recovery into one configurable, closed-system platform. Cellipont Bioservices’ recent white paper, now available to download, presents the newest data demonstrating the platform’s performance across different operating scales. 👉 Download the White Paper, "Scaling Cell and Gene Therapy Manufacturing With Automated Formulation and Fill-Finish.”: https://lnkd.in/gfE5gGZS At Xiogenix, we work closely with our partners to understand each workflow and build the right path for greater flexibility, control, and scale. 👉 Consult with Our Team Directly: https://lnkd.in/gJE9JrhU #CellTherapy #CellTherapyManufacturing #FillFinish

What does automated fill-finish actually look like in practice? In Cellipont Bioservices's latest white paper, they take a closer look at ARES™ X20+ performance across small- and large-scale workflows, including post-thaw viability, fill variability and fill accuracy. A few of the key findings are highlighted here, with the full study going deeper into the data and methodology. Interested in the full paper? Sign up for a copy here: https://lnkd.in/gfE5gGZS #CellAndGeneTherapy #FillFinish #Biomanufacturing #Automation

A new white paper evaluating the ARES™ X20+ is now available. "Scaling Cell and Gene Therapy Manufacturing with Automated Formulation and Fill-Finish", published by Cellipont Bioservices in collaboration with Xiogenix, evaluates the ARES™ X20+ across small- and large-scale workflows, with findings focused on fill performance, process efficiency, cell quality, and process control. The paper adds real-world data to the conversation around moving critical downstream steps beyond manual processing. Request the White Paper: https://lnkd.in/gfE5gGZS Read the Official Press Release: https://lnkd.in/gKHw_yXb Thank you to Cellipont Bioservices for the collaboration and for contributing valuable data to the future of automated formulation and fill-finish. For more information on the ARES™ X20+ Fill-Finish System, visit xiogenix.com/ares-x20 and contact our team at xiogenix.com/contact. #cellandgenetherapy #fillfinish #formulation #newdata

𝐍𝐞𝐰 𝐰𝐡𝐢𝐭𝐞 𝐩𝐚𝐩𝐞𝐫 𝐧𝐨𝐰 𝐚𝐯𝐚𝐢𝐥𝐚𝐛𝐥𝐞. Scaling cell therapy manufacturing is not simply about producing more cells — the downstream process has to scale with the therapy, too. Cellipont Bioservices and Xiogenix collaborated to evaluate the ARES™ X20+ automated fill-finish platform across small- and large-scale cell therapy manufacturing workflows. Among the findings: • Consistent formulation performance across an approximately17-𝐟𝐨𝐥𝐝 𝐢𝐧𝐜𝐫𝐞𝐚𝐬𝐞 𝐢𝐧 𝐩𝐫𝐨𝐜𝐞𝐬𝐬 𝐬𝐜𝐚𝐥𝐞 • Final formulation volume accuracy of 2% 𝐚𝐭 𝐬𝐦𝐚𝐥𝐥 𝐬𝐜𝐚𝐥𝐞 𝐚𝐧𝐝 103.6% 𝐚𝐭 𝐥𝐚𝐫𝐠𝐞 𝐬𝐜𝐚𝐥𝐞 •𝐒𝐭𝐚𝐛𝐥𝐞 𝐜𝐞𝐥𝐥 𝐯𝐢𝐚𝐛𝐢𝐥𝐢𝐭𝐲 before and after automated formulation The study offers practical insight into how automation may help bring greater consistency, flexibility, and manufacturing readiness as cell therapy programs advance. 📄 𝐆𝐞𝐭 𝐲𝐨𝐮𝐫 𝐜𝐨𝐩𝐲 𝐨𝐟 𝐭𝐡𝐞 𝐰𝐡𝐢𝐭𝐞 𝐩𝐚𝐩𝐞𝐫: https://lnkd.in/gMUe5iwd 📰 𝐑𝐞𝐚𝐝 𝐭𝐡𝐞 𝐟𝐮𝐥𝐥 𝐚𝐧𝐧𝐨𝐮𝐧𝐜𝐞𝐦𝐞𝐧𝐭 𝐚𝐧𝐝 𝐩𝐫𝐞𝐬𝐬 𝐫𝐞𝐥𝐞𝐚𝐬𝐞: https://lnkd.in/gKHw_yXb And if you’ll be at the CAR-TCR Summit in Boston, September 15–17, connect with our team to talk about the findings and what they could mean for your program. #CellTherapy #CellTherapyManufacturing #FillFinish #Automation #CGT #ScaleUp #Biomanufacturing

As cell therapy programs advance, manual fill-finish can become increasingly difficult to scale. In a new white paper, Cellipont Bioservices evaluates the ARES™ X20+ across small-scale vial and larger-scale bag workflows, exploring how automation can support formulation and fill-finish as process requirements evolve. See the performance data and results when the full white paper launches September 9. Want a copy sent directly to you when it goes live? Request it here: https://lnkd.in/gfE5gGZS #CellandGeneTherapy #FillFinish #ARESX20Plus